Volume: 11 Issue: 1
Year: 2023, Page: 68-73, Doi: https://doi.org/10.47799/pimr.1101.11
Received: Jan. 25, 2023 Accepted: Feb. 16, 2023 Published: Feb. 16, 2023
In India Mass Drug Administration (MDA) drive is undertaken every year. In mass drug administration DEC and Albendazole combination is used. For the strategy to be effective, more than 85% of those living in endemic areas must be covered by MDA.
Methods: This is a cross-sectional study in which family clusters were selected from rural and urban areas. Information about coverage, compliance with MDA and knowledge of filariasis was obtained using a questionnaire. Data were analysed using percentages and proportions.
Results: In this study, about 92.51% of the study participants received DEC and ABZ tablets during MDA, of which 95.14 % of participants consumed the drugs. The most common cause of noncompliance was fear of side effects.
Conclusion: Coverage of the population with DEC and albendazole combination was good but compliance needs to be improved. IEC activities should be intensified. Local leaders should be involved in the programme to increase compliance.
Keywords: MDA, DEC, Coverage, Compliance, Filaria
Suryakantha, A H . 2017. Community Medicine with Recent Advances. Fourth ed. The Health Sciences publisher. (pp. 455-462) New:
National Vector Borne Disease Control Program 2018. Global LF situation. Accelerated plan for elimination of lymphatic filariasis. https://nvbdcp.gov.in/WriteReadData/l892s/1031567531528881007.pdf. https://nvbdcp.gov.in/WriteReadData/l892s/1031567531528881007.pdf
Ministry of Health and Family Welfare, New Delhi 2020. Government of India: Annual report 2019-2020.
National Center for Vector Borne Diseases Control 2009. Guidelines for filarial control and its elimination 2009. Implementation of mass drug administration. National Center for Vector Borne Diseases Control (NCVBDC) (nvbdcp.gov.in). https://nvbdcp.gov.in/index1.php?lang=1&level=1&sublinkid=5899&lid=3686
National Vector Borne Disease Control Program 2018. Introduction: Accelerated plan for elimination of lymphatic filariasis. https://nvbdcp.gov.in/WriteReadData/l892s/1031567531528881007.pdf
National Vector Borne Disease Control Program Chapter 3: Mass Drug Administration. Progress and achievement. In: Guidelines on Elimination of Lymphatic Filariasis India. Ministry of Health and Family Welfare
World Health Organization 2020. Lymphatic filariasis key facts. https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis#:~:text=Lymphatic%20filariasis%2C%20commonly%20known%20as
World Health Organization Lymphatic filariasis: reporting continued progress towards elimination as a public health problem. https://www.who.int/news/item/29-10-2020-lymphatic-filariasis-reporting-continued-progress-towards-elimination-as-a-public-health-problem
Patel, P K . 2012. Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Community Med 37:101–107.
Bhatia, V, Giri, P P, Sahoo, S S, Ps P, & Sahu, D P . 2008. Mass Drug Administration (MDA) for Elimination of Lymphatic Filariasis: Experiences from Nayagarh District of Odisha. India. Indian J Community Health 30(3):287–92.
Bikash Chandra Nayak1, Aurobindo, Samantaray2, Y & Bharani Krishna3, . 2020. Assessment of Mass Drug Administration activities for Lymphatic Filariasis Elimination in Vizianagaram District of. Andhra PradeshIndian Journal of Public Health Research & Development 11(6).
Prasad, & Nagendra, K . 2017. An evaluation of mass drug administration for lymphatic filariasis in Bidar district. International Journal of Medical Science and Public Health 6:1020–1023.
Gururraj, N . 2021. Coverage Evaluation Survey of Mass Drug Administration Strategy to Eliminate Lymphatic Filariasis in North Karnataka Region. Are We on Track. Annals of Community Health 2347–5714.
Aswathy, S, Beteena, K & Leelamoni, K . 2009. Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala. Ann Trop Med Parasitol 103(7):617–641.
Barman, S K, Kumar, N, Barman, S, Maroof, M, Chouhan, Rrs & Yadav, M . 2022. Coverage evaluation of Mass Drug Administration (MDA) for lymphatic filariasis in a district of Bundelkhand Region of Uttar Pradesh. Indian J Comm Health 34(2):170–175.
Banerjee, S, Bandyopadhyay, K, Khan, M F, Akkilagunta, S, Selvaraj, K, Tripathy, J P, Solanki, R, Kushwaha, A S & Deshmukh, P . 2019. Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study. J Family Med Prim Care 8:6820416.
Hussain, Mubeen . 2013. Evaluation of mass drug administration campaign against Lymphatic Filariasis at Bidar district. 3561+. Gale Academic OneFile, link.gale.com/apps/doc/A362962553/AONE?u=googlescholar&sid=bookmark-AONE&xid=6e8a02c3. Accessed 2.
Rajkumar, P S, Pandve, T K, Nagaiah, G, Tajmul, S, Arun, B & Inamdar, N S . 2016. An Operational Research on Annual Mass Drug Administration (MDA) For Elimination of Lymphatic Filariasis in Medak District. Telangana. IA? 3(7):239–283.
Jothula, K Y, Naidu, N K, Malhotra, V M, Prasad, V G, Kabra, P R & Nagaraj, K . Evaluation of mass drug administration programme for elimination of lymphatic filariasis in Nalgonda district. Int J Community Med Public Health .
Perni, S G, Motghare, D D, Ferreira, A M, Perni, S S, Vaz, F S, Kulkarni, M S & Govekar, S . 2015. Evaluation of mass drug administration for elimination of lymphatic filariasis in Goa, India. Int J Community Med Public Health 2(3):259–62.
Ram, S, Prakash, S, Singh, R, Prakash, G & Anand, D . 2021. A study on coverage and compliance of mass drug administration for lymphatic filariasis in Prayagraj District. Int J Community Med Public Health 8:1454–1463.
Kulkarni, P, Amoghashree, , Krishnaveni, Y S, Murthy, Narayana, Kumar, M R & K R . 2018. Coverage and compliance towards mass drug administration programme against lymphatic filariasis in Vijayapura. Int J Community Med Public Health 5:4311–4316.
Ghosh, S, Samanta, A & Kole, S . 2013. Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal. India. Trop Parasitol 3(1):3745675.
Pattanshetty, S, Kumar, A, Kumar, R, Rao, C R, Badiger, S, Rashmi, R & Kamath, S . Mass drug administration to eliminate lymphatic filariasis in Southern India. AMJ 2010.
Hussain, M A, Sitha, A K, Swain, S, Kadam, S & Pati, S . 2014. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty 3:4166397.
Kumar, Ashwini, Kumar, Pawan, Nagaraj, Kondagunta, Nayak, Divakar, Ashok, Lena & Ashok, & K . 2009. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district. J Vector Borne Dis 46:237–240.
Acharya, Himansu Prasad, Pradhan, Subrat Kumar, Satapathy, Durga Madhab, Mishra, Rudra Prasanna & Sinha, Upasana . 2018. EVALUATION OF MASS DRUG ADMINISTRATION FOR FILARIASIS IN BOUDH DISTRICT, ODISHA. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS 7(13):1584–1587.
Sayyad T, Md MA, Khaja AJ, Bhayya S. Assessment of coverage and compliance of mass drug administration for lymphatic filariasis in Medak District-2021. Perspectives in Medical Research. 2023;11(1):68-73 DOI: 10.47799/pimr.1101.11